Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients. - Wikidata - awgldk - TriplyDB

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

http://www.wikidata.org/entity/Q43773570

about

Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients Serum erythropoietin level and mortality in kidney transplant recipients High serum erythropoietin levels are related to heart failure development in subjects from the general population with albuminuria: data from PREVEND.Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin.Effect of erythropoietin levels on mortality in old age: the Leiden 85-plus Study The cardiorenal syndrome: a review Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin Timing and determinants of erythropoietin deficiency in chronic kidney disease.Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives.Pharmacologic Management of the Cardio-renal Syndrome.Anemia in heart failure: pathophysiologic insights and treatment options.Erythropoietin and the heart: facts and perspectives.Erythropoiesis-stimulating agents and heart failure.Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.Erythropoietin: a future therapy for failing hearts?Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis.Iron deficiency anemia in heart failure.Co-morbidities in heart failure.Heart failure highlights in 2012-2013.Prognostic significance of endogenous erythropoietin in long-term outcome of patients with acute decompensated heart failure.Effects of erythropoiesis-stimulating agents on heart failure patients with anemia: a meta-analysis.An emerging need for developing new models for myocardial infarction as a chronic complex disease: lessons learnt from animal vs. human studies on cardioprotective effects of Erythropoietin in reperfused myocardium.A single dose of erythropoietin in ST-elevation myocardial infarction.Bone marrow dysfunction in chronic heart failure patients.Erythropoietin and heart failure: the end of a promise?Anemia is associated with an increased central venous pressure and mortality in a broad spectrum of cardiovascular patients.Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function.

P2860

Q24241045-709F264D-AC72-44D4-B3F4-DD337EDB97CE Q30423606-A55AA711-9885-45A1-9BE9-242002E90C9E Q31037729-1E032A02-6F0C-4CD2-AB5E-28D88398AE55 Q33750384-59592B5D-07EB-4BF4-9DFA-06A7864AE761 Q34403856-0019EAA9-11CC-4B6D-BB06-BC33842DC2DE Q34495307-BE8EE7FA-B1B8-4B07-B7B0-D41BA2E7D6C8 Q34663709-3488636F-0241-4228-B50B-5868CF7FAC5A Q35692480-20C8BB9F-EEC7-4C65-8803-8F648E769A02 Q36682182-13591D52-389F-41DA-B48F-7AC7FF2BC446 Q37089975-4EC199BA-D014-4131-8D7A-9BC76BA9987D Q37445907-FA66C77A-29DC-4DA5-B407-BBE5A453033F Q37798565-BFC62255-5FBC-472B-AE8E-3B26CB13C5A2 Q37802925-6D4CEB03-73EE-4DDC-BCBA-852C93F9B438 Q37883005-8D005BDA-F4A5-4646-8B3F-D0BEFE3C22B4 Q37952603-D11B27DC-8CD3-4120-B983-025C080E8469 Q37986258-83D90BA6-157A-4B8A-A8B9-054AA23EA3AF Q38040656-D1AF5B81-0467-4664-A111-A9111126C1C2 Q38069787-E1455F8C-BBA4-445A-91A2-5BF516977D25 Q38182010-DAB68DBA-D5A5-4A2A-91AA-F9E1CF3384C3 Q40776947-01FDC75D-A086-4E76-9247-79E844481B30 Q41016380-038C1E98-DBE4-4BEF-928A-48DFBEB54ACC Q41943331-E6C35492-4A6A-4989-B90B-067D4CB9FD7D Q42923034-E56C5B61-4CB9-40B9-A50B-20BC76B1E2C0 Q43081654-839411CD-149C-42BE-83D0-37A85513A611 Q43749166-6A6969EF-8207-471C-A06F-EABCC97F9999 Q44842334-C6E13952-B3A7-4527-A9F9-5636E25D8B3B Q45721982-02753614-EDD5-4D34-855E-86863336ED63

P2860

Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.

http://www.wikidata.org/entity/Q43773570

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Adequacy of endogenous erythro ...... naemic heart failure patients.

@en

Adequacy of endogenous erythro ...... naemic heart failure patients.

@nl

type

label

Adequacy of endogenous erythro ...... naemic heart failure patients.

@en

Adequacy of endogenous erythro ...... naemic heart failure patients.

@nl

prefLabel

Adequacy of endogenous erythro ...... naemic heart failure patients.

@en

Adequacy of endogenous erythro ...... naemic heart failure patients.

@nl

P1433

Q43773570-F87690A3-6DE5-4CE4-A1EF-FD1467ADB4B2

P1476

Q43773570-0E70B767-1D6C-4D42-B99E-6413E116985E

P2093

Q43773570-1E94051B-943E-42AF-B799-81A986F5327F

Q43773570-6332F7FE-7A1E-4A61-852C-6ACBA3826FF8

Q43773570-B50F1BD6-87A0-4C47-B96C-C4A8D75BEE86

Q43773570-CA1E71C4-0D20-426C-9E4C-A805909FDE6F

Q43773570-D4A729D9-B043-43A2-A320-D542629A68BD

Q43773570-E1754FFE-E12D-463D-B001-7B8A129D205D

P2860

Q43773570-09822F91-7C21-48D0-A63F-8C04ED799FBD

Q43773570-0D52355D-E840-4E71-ADB8-7AFF70F9DADC

Q43773570-142586F0-5415-4DC3-85BE-7F9C00F5DA53

Q43773570-2EF5647A-E4FD-4876-99B0-D933D2353F69

Q43773570-375C09F8-ED0C-4C6E-82A7-789E6DD7227D

Q43773570-3D1DB92B-1590-4330-BF7C-E5C7C05D52D8

Q43773570-46501EE1-CCFE-48EA-A772-03AAF3BB998E

Q43773570-4857F268-4BB3-49A8-9F76-D706CE6FABC1

Q43773570-57BCA333-C0F1-444F-9CEE-1B82C2DEA393

Q43773570-5A7F6083-3632-4A4B-AF1A-4AA4B3783A5E

P304

Q43773570-FF0E91CE-7737-471D-BEA6-0136AEAD957A

P31

Q43773570-B44751B9-377E-4B6E-9DCB-9884E78AC493

P356

Q43773570-2FEA09D4-2628-4010-B923-9964B1151827

P433

Q43773570-CA521EE3-CE3D-4B96-8EF9-F095194F90C6

P478

Q43773570-99D10B4F-4014-4C09-B807-6222AA591365

P50

Q43773570-733D0175-D3FD-4CD7-B9F2-0890CC0D9A41

Q43773570-9C84F281-EAA3-41F2-929C-061DF9CE5B20

Q43773570-ED2F61FC-2D16-42D8-B057-50E1AE86B3C1

P577

Q43773570-04E44398-5E32-4E62-B8F5-CB80D45135D3

P5875

Q43773570-70A2C7AA-CC23-445B-96B6-5505C6F0591F

P698

Q43773570-128F158A-B99C-4E7C-BBC5-AFBDCD55F3B3

P921

Q43773570-1F12C8D5-83AA-4947-84CC-67113CCEFB0A

P356

P1433

European Heart Journal

P1476

Adequacy of endogenous erythro ...... naemic heart failure patients.

@en

P2093

Adriaan A Voors

http://www.w3.org/2001/XMLSchema#string

Dirk J Lok

http://www.w3.org/2001/XMLSchema#string

Erik Lipsic

http://www.w3.org/2001/XMLSchema#string

Jan van Wijngaarden

http://www.w3.org/2001/XMLSchema#string

Peter van der Meer

http://www.w3.org/2001/XMLSchema#string

Pieta W Bruggink-Andre de la Porte

http://www.w3.org/2001/XMLSchema#string

P2860

Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial

The importance of anemia and its correction in the management of severe congestive heart failure

Erythropoietin in cardiovascular diseases.

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study

Prevalence of anemia and effects on mortality in patients with heart failure.

Basic mechanisms in heart failure: the cytokine hypothesis.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.

C-reactive protein in heart failure: prognostic value and the effect of valsartan.

Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.

P304

1510-1515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHN205

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Wiek H van Gilst

James L Januzzi

Dirk J van Veldhuisen

P577

2008-05-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5353972

http://www.w3.org/2001/XMLSchema#string

P698

18495690

http://www.w3.org/2001/XMLSchema#string

P921